**Abstract**

**Objective:** To investigate the association between DNA methylation in peripheral blood cells and abstinence in alcoholics treated with acamprosate.

**Methods:** Illumina Infinium 450k HumanMethylation BeadChip was utilized to assess the genome-wide methylation status of approximately 500,000 CpGs in 26 peripheral blood DNA samples collected from 13 subjects before and after 3 months of acamprosate treatment. A subset of 627 methylation probes was selected based upon variability within paired samples. Unsupervised hierarchical clustering and principal component analysis (PCA) were performed using this subset of probes, followed by tests of association of the resulting clusters and principal components with 3 month abstinence. Ingenuity Pathway Analysis (IPA) was used for functional assessment of the 54 most differentially methylated CpGs.

**Results:** A DNA methylation signature based on 627 CpGs was associated (p=4.88E-04) with abstinence during acamprosate treatment. The samples clustered based upon sobriety vs. relapse, rather than acamprosate effect on the DNA methylation landscape. The association remained significant (adjusted p=4.73E-3) after adjustment for potential confounders (study site, number of days since last drink, and craving score). Separation of the methylation signatures from relapsers and abstainers was also confirmed by PCA analysis. Functional assessment with IPA showed enrichment for pathways including "Drug Metabolism", "Uptake of Dopamine" and "Neurological Disease". Moreover, one of the aberrantly methylated CpG is located in the 3' UTR of the SLC6A3 gene, encoding a dopamine transporter, which has been implicated in a variety of psychiatric disorders, alcoholism, and was also associated with an ability to quit smoking.

**Conclusion:** This is a first report associating DNA methylation signature with abstinence in alcoholics treated with acamprosate. Future studies are needed to investigate the value of this association as a potential biomarker of acamprosate response in treatment-seeking alcoholics.
